Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract B179: 2-Deoxy-D-glucose (2-DG) combination with ketogenic diet induces sedation and hypothermia in mice that becomes lethal

Rafal Zielinski, Moises Martinez Castillo, Damian Grybowski, Krzysztof Grela, Roberto Cardenas-Zuniga, Izabela Fokt, Stanislaw Skora, Gerardo Ramirez, Waldemar Priebe

Mol Cancer Ther (2023) 22 (12_Supplement): B179.

https://doi.org/10.1158/1535-7163.TARG-23-B179

Published: 01 December 2023

View articletitled, Abstract B179: 2-Deoxy-D-glucose (2-DG) combination with ketogenic diet induces sedation and hypothermia in mice that becomes lethal

Journal Articles

Abstract P218: Annamycin, a novel non-cardiotoxic anthracycline with high activity against sarcomas metastatic to lungs

Rafal Zielinski, Krzysztof Grela, Roberto Cardenas-Zuniga, Stanislaw Skora, Izabela Fokt, Maria Poimenidou, Salah-Eddine Lamhamedi-Cherradi, Joseph Ludwig, Waldemar Priebe

Mol Cancer Ther (2021) 20 (12_Supplement): P218.

https://doi.org/10.1158/1535-7163.TARG-21-P218

Published: 01 December 2021

View articletitled, Abstract P218: Annamycin, a novel non-cardiotoxic anthracycline with high activity against sarcomas metastatic to lungs

Journal Articles

Abstract P129: Ketogenic diet (KD) and targeting Warburg effect: Apparent toxicity of KD combination with 2-deoxy-D-glucose

Rafal Zielinski, Maria Poimenidou, Matthew Khuong, Krzysztof Grela, Roberto Cardenas-Zuniga, Stanislaw Skora, Izabela Fokt, Michael Gagea, Jody Swain, Sigmund Zhou, Waldemar Priebe

Mol Cancer Ther (2021) 20 (12_Supplement): P129.

https://doi.org/10.1158/1535-7163.TARG-21-P129

Published: 01 December 2021

View articletitled, Abstract P129: Ketogenic diet (KD) and targeting Warburg effect: Apparent toxicity of KD combination with 2-deoxy-D-glucose

Journal Articles

Abstract C094: Dose and schedule-dependent efficacy of liposomal Annamycin in pre-clinical models of acute myeloid leukemia

Rafal Zielinski, Tomasz Zal, Krzysztof Grela, Stanislaw Skora, Izabela Fokt, Matthew Sander, Magdalena Remiszewski, Edward Felix, Meenakshi Shanmugasundaram, Waldemar Priebe

Mol Cancer Ther (2019) 18 (12_Supplement): C094.

https://doi.org/10.1158/1535-7163.TARG-19-C094

Published: 01 December 2019

View articletitled, Abstract C094: Dose and schedule-dependent efficacy of liposomal Annamycin in pre-clinical models of acute myeloid leukemia

Journal Articles

Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo: Therapeutic Implications

Lan V. Pham, Archito T. Tamayo, Changping Li, William Bornmann, Waldemar Priebe, Richard J. Ford

Mol Cancer Ther (2010) 9 (7): 2026–2036.

https://doi.org/10.1158/1535-7163.MCT-10-0238

Published: 07 July 2010

View articletitled, Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo: Therapeutic Implications

Includes: Supplementary data

Journal Articles

Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

Jun Wei, Jason Barr, Ling-Yuan Kong, Yongtao Wang, Adam Wu, Amit K. Sharma, Joy Gumin, Verlene Henry, Howard Colman, Waldemar Priebe, Raymond Sawaya, Frederick F. Lang, Amy B. Heimberger

Mol Cancer Ther (2010) 9 (1): 67–78.

https://doi.org/10.1158/1535-7163.MCT-09-0734

Published: 12 January 2010

View articletitled, Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

Journal Articles

Abstract C98: Blocking glycolysis with 2‐deoxy‐D‐glucose prodrugs to target brain tumors: A novel concept

Waldemar Priebe, Marcin Cybulski, Izabela Fokt, Stanislaw Skora, Charles A. Conrad, Timothy Madden

Mol Cancer Ther (2009) 8 (12_Supplement): C98.

https://doi.org/10.1158/1535-7163.TARG-09-C98

Published: 10 December 2009

View articletitled, Abstract C98: Blocking glycolysis with 2‐deoxy‐D‐glucose prodrugs to target brain tumors: A novel concept

Journal Articles

Abstract C214: WP769, an orally bioavailable blood‐brain barrier penetrating anthracycline

Timothy Madden, Mary J. Johansen, Izabela Fokt, Jay Thapar, Charles Conrad, Waldemar Priebe

Mol Cancer Ther (2009) 8 (12_Supplement): C214.

https://doi.org/10.1158/1535-7163.TARG-09-C214

Published: 10 December 2009

View articletitled, Abstract C214: WP769, an orally bioavailable blood‐brain barrier penetrating anthracycline

Journal Articles

Phase I clinical pharmacokinetics of RTA 744 (berubicin(B)), a blood-brain barrier penetrating anthracycline active against high grade glioma, and evaluation of its 13-hydroxy metabolite, berubicinol (B-ol)

Reza Kazerooni, Charles Conrad, Mary Johansen, Mick Sakamoto, Neil Thapar, Colin Meyer, Waldemar Priebe, Timothy Madden

Mol Cancer Ther (2007) 6 (11_Supplement): B101.

Published: 01 November 2007

View articletitled, Phase I clinical pharmacokinetics of RTA 744 (berubicin(B)), a blood-brain barrier penetrating anthracycline active against high grade glioma, and evaluation of its 13-hydroxy metabolite, berubicinol (B-ol)

Journal Articles

WP760, a new DNA-binding agent with unique melanoma selectivity

Claudia Schroeder, Izabela Fokt, Mary Johansen, Robyn Rhea, Tracy Allen, Timothy Madden, Waldemar Priebe

Mol Cancer Ther (2007) 6 (11_Supplement): A219.

Published: 01 November 2007

View articletitled, WP760, a new DNA-binding agent with unique melanoma selectivity

Journal Articles

Inhibition of glycolysis and induction of autophagy in gliomas by 2-fluoro-deoxy-D-glucose.

Leposava Antonovic, Izabela Fokt, Slawomir Szymanski, Charles Conrad, Waldemar Priebe, Timothy Madden

Mol Cancer Ther (2007) 6 (11_Supplement): B34.

Published: 01 November 2007

View articletitled, Inhibition of glycolysis and induction of autophagy in gliomas by 2-fluoro-deoxy-D-glucose.

Journal Articles

2-Deoxy-D-glucose induces Type II cell death in pancreatic cancer.

Leposava Antonovic, Mary Johansen, Izabela Fokt, Slawomir Szymanski, Charles Conrad, Waldemar Priebe, Timothy Madden

Mol Cancer Ther (2007) 6 (11_Supplement): B35.

Published: 01 November 2007

View articletitled, 2-Deoxy-D-glucose induces Type II cell death in pancreatic cancer.

Journal Articles

Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues

Alex V. Trevino, Barbara A. Woynarowska, Terence S. Herman, Waldemar Priebe, Jan M. Woynarowski

Mol Cancer Ther (2004) 3 (11): 1403–1410.

https://doi.org/10.1158/1535-7163.1403.3.11

Published: 12 November 2004

View articletitled, Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract B179: 2-Deoxy-D-glucose (2-DG) combination with ketogenic diet induces sedation and hypothermia in mice that becomes lethal

Abstract P218: Annamycin, a novel non-cardiotoxic anthracycline with high activity against sarcomas metastatic to lungs

Abstract P129: Ketogenic diet (KD) and targeting Warburg effect: Apparent toxicity of KD combination with 2-deoxy-D-glucose

Abstract C094: Dose and schedule-dependent efficacy of liposomal Annamycin in pre-clinical models of acute myeloid leukemia

Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo: Therapeutic Implications

Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

Abstract C98: Blocking glycolysis with 2‐deoxy‐D‐glucose prodrugs to target brain tumors: A novel concept

Abstract C214: WP769, an orally bioavailable blood‐brain barrier penetrating anthracycline

Phase I clinical pharmacokinetics of RTA 744 (berubicin(B)), a blood-brain barrier penetrating anthracycline active against high grade glioma, and evaluation of its 13-hydroxy metabolite, berubicinol (B-ol)

WP760, a new DNA-binding agent with unique melanoma selectivity

Inhibition of glycolysis and induction of autophagy in gliomas by 2-fluoro-deoxy-D-glucose.

2-Deoxy-D-glucose induces Type II cell death in pancreatic cancer.

Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only